Michael Al Pilato Sells 16,582 Shares of Jamieson Wellness Inc. (TSE:JWEL) Stock

Jamieson Wellness Inc. (TSE:JWEL) Director Michael Al Pilato sold 16,582 shares of the business’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of C$28.62, for a total transaction of C$474,571.87.

Jamieson Wellness Stock Up 1.6 %

Shares of TSE:JWEL opened at C$28.68 on Friday. The company has a debt-to-equity ratio of 75.70, a quick ratio of 1.08 and a current ratio of 2.76. The firm has a market capitalization of C$1.20 billion, a PE ratio of 30.13 and a beta of 0.63. The firm has a fifty day moving average of C$33.40 and a 200 day moving average of C$34.19. Jamieson Wellness Inc. has a 52-week low of C$23.98 and a 52-week high of C$38.20.

Jamieson Wellness Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, March 14th will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 2.93%. The ex-dividend date of this dividend is Friday, March 7th. Jamieson Wellness’s dividend payout ratio is presently 88.26%.

Wall Street Analysts Forecast Growth

JWEL has been the subject of a number of recent analyst reports. National Bankshares boosted their price target on shares of Jamieson Wellness from C$36.50 to C$42.00 in a research report on Monday, November 25th. Royal Bank of Canada upped their target price on shares of Jamieson Wellness from C$38.00 to C$41.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 25th. TD Securities upped their target price on shares of Jamieson Wellness from C$40.00 to C$42.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, BMO Capital Markets upped their target price on shares of Jamieson Wellness from C$42.00 to C$46.00 in a research report on Thursday, December 19th.

Jamieson Wellness Company Profile

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.